European Commission: ‘ELF is leading the way to discovering new medicines’

27 February 2018

Under the topic “Success Stories”, the European Commission recognises the impact and potential of the European Lead Factory. The Directorate-General Research and Innovation highlighted that ‘researchers working on any human disease can call on a great resource to develop new drugs.’ 

ELF has created an integrated platform which is providing an innovative range of free services, expertise and a huge collection of compounds for researchers who are developing new drugs. The ELF target portfolio covers a wide range of therapeutic areas with high societal relevance, also including neglected and rare diseases. The project gives European drug discovery programmes a boost and aids their progression. For example, two start-up companies were established based on ELF results.

The European Commission concludes: ‘ELF is playing a leading role in delivering the innovative services and expertise necessary to find and innovative new drugs to the benefit of researchers, the medical industry and patients alike.’

Read the complete article here.